Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Viatris Inc (VTRS)

Viatris Inc (VTRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
MSM
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky StockStory - Thu May 21, 11:38PM CDT

1 Unpopular Stock That Should Get More Attention and 2 We Find Risky

MSM : 109.47 (-0.28%)
VTRS : 16.26 (+0.93%)
PL : 51.14 (-0.51%)
VTRS
Viatris (VTRS): Buy, Sell, or Hold Post Q1 Earnings? StockStory - Tue May 19, 11:36PM CDT

Viatris (VTRS): Buy, Sell, or Hold Post Q1 Earnings?

VTRS : 16.26 (+0.93%)
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain PR Newswire - Mon May 18, 7:00AM CDT

FDA PDUFA Goal Date Set for Dec. 27, 2026

VTRS : 16.26 (+0.93%)
ZUMZ
1 Stock Under $50 to Target This Week and 2 We Avoid StockStory - Thu May 14, 11:32PM CDT

1 Stock Under $50 to Target This Week and 2 We Avoid

ZUMZ : 24.63 (-2.73%)
VTRS : 16.26 (+0.93%)
LC : 17.85 (+4.82%)
VTRS
5 Revealing Analyst Questions From Viatris’s Q1 Earnings Call StockStory - Thu May 14, 12:39AM CDT

5 Revealing Analyst Questions From Viatris’s Q1 Earnings Call

VTRS : 16.26 (+0.93%)
MRCY
3 Unprofitable Stocks That Fall Short StockStory - Sun May 10, 11:38PM CDT

3 Unprofitable Stocks That Fall Short

NNBR : 2.97 (-3.57%)
VTRS : 16.26 (+0.93%)
MRCY : 111.70 (+3.32%)
VTRS
VTRS Q1 Deep Dive: China Strength, R&D Pipeline, and Execution Drive Outperformance StockStory - Fri May 8, 12:38AM CDT

VTRS Q1 Deep Dive: China Strength, R&D Pipeline, and Execution Drive Outperformance

VTRS : 16.26 (+0.93%)
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference PR Newswire - Thu May 7, 3:30PM CDT

PITTSBURGH , May 7, 2026 /PRNewswire/ -- Viatris Inc . (Nasdaq: VTRS), a global healthcare company, today announced that the Company will present at the Bank of America Securities 2026 Healthcare...

VTRS : 16.26 (+0.93%)
VTRS
Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue StockStory - Thu May 7, 6:19AM CDT

Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue

VTRS : 16.26 (+0.93%)
Viatris: Q1 Earnings Snapshot AP - Thu May 7, 6:06AM CDT

Viatris: Q1 Earnings Snapshot

VTRS : 16.26 (+0.93%)

Barchart Exclusives

Barclays Says Sandisk’s New AI Contracts Could Change the Memory Industry Barchart - Sun May 31, 2:00PM CDT
Sandisk stock is surging after Barclays highlighted the company’s aggressive long-term AI memory contracts and structurally stronger earnings outlook. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.